We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
71 hedge funds and large institutions have $73.1M invested in Zevra Therapeutics in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
195% more call options, than puts
Call options by funds: $19.9M | Put options by funds: $6.77M
50% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 16
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
1% more funds holding
Funds holding: 70 → 71 (+1)
0.36% less ownership
Funds ownership: 22.63% → 22.27% (-0.36%)
25% less capital invested
Capital invested by funds: $98.1M → $73.1M (-$25M)
Holders
71
Holders Change
+1
Holders Change %
+1.43%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
24
Reduced
16
Closed
12
Calls
$19.9M
Puts
$6.77M
Net Calls
+$13.2M
Net Calls Change
-$3.72M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.87M |
| 2 |
Goldman Sachs
New York
|
+$1.7M |
| 3 |
Renaissance Technologies
New York
|
+$1.67M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.44M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.02M |
